Phase I/II Trial of X-396, a Novel ALK Inhibitor, in Patients With ALK plus NSCLCTiciana Leal,Heather Wakelee,Jeffrey Infante,George Blumenschein,Karen Reckamp,Corey Carter,Saiama Waqar,Jon Gockerman,Christine Lovly,Gary Dukart,Kimberly Harrow,Chris Liang,James Gibbons,Leora HornJOURNAL OF THORACIC ONCOLOGY(2016)引用 0|浏览19暂无评分关键词X-396,ALK plus NSCLCAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要